Mon, December 14, 2020
Fri, December 11, 2020
Thu, December 10, 2020
Wed, December 9, 2020
Tue, December 8, 2020
Mon, December 7, 2020
Fri, December 4, 2020
Thu, December 3, 2020
Wed, December 2, 2020
Tue, December 1, 2020
Mon, November 30, 2020
Sun, November 29, 2020

David Lebowitz Maintained (SNDX) at Hold with Increased Target to $25 on, Dec 7th, 2020


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-increased-target-to-25-on-dec-7th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebowitz of Morgan Stanley, Maintained "Syndax Pharmaceuticals, Inc." (SNDX) at Hold with Increased Target from $17 to $25 on, Dec 7th, 2020.

David has made no other calls on SNDX in the last 4 months.



There is 1 other peer that has a rating on SNDX. Out of the 1 peers that are also analyzing SNDX, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Konstantinos Aprilakis of "Stifel" Initiated at Strong Buy and Held Target at $32 on, Thursday, December 3rd, 2020

Publication Contributing Sources